update from murano trial: venetoclax-rituximab leads to slower clonal growth rate in cll
Published 2 years ago • 202 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
2:13
venetoclax rituximab for r/r cll: 7-year results of the murano trial
-
6:25
murano: five-year follow-up on venetoclax plus rituximab for cll
-
2:21
updates from the murano trial
-
2:57
murano trial: duvelisib plus venetoclax in r/r cll, sll and richter’s syndrome
-
2:04
murano trial: revolutionizing the standard of care for relapsed cll patients
-
36:35
linc 2023 - treatment of clti: new horizons with novel dcb technology
-
24:09
update on venetoclax for cll
-
4:52
apoptosis and venetoclax
-
3:00
flair trial: improved outcomes with mrd-guided ibrutinib plus venetoclax in cll compared to fcr
-
5:17
venetoclax and rituximab: changing the treatment landscape in r/r cll
-
0:51
long-term post hoc analysis of murano trial: host immune changes following venr treatment in cll
-
1:01
pirtobrutinib, venetoclax, and rituximab in the treatment of r/r cll: insights from the bruin trial
-
2:20
murano: venetoclax rituximab in birc3-mutated r/r cll
-
2:04
time-limited venetoclax-rituximab in r/r cll patients previously exposed to btki’s
-
4:08
murano update: sustained benefit for time-limited venr & biomarkers for response in cll
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
3:12
results of the murano study for cll
-
0:58
updates from the phase iii sequoia trial: zanubrutinib vs. br in the treatment of patients with cll
-
4:21
hovon 141/vision trial update: mrd-guided venetoclax ibrutinib treatment for r/r cll
-
3:19
an update on two trials evaluating venetoclax in subsets of cll
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
0:45
key trials in cll and designing a concept for treatment